Cargando…

JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases

The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia areata. Patients suffering from other ISDs might a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alves de Medeiros, Ana Karina, Speeckaert, Reinhart, Desmet, Eline, Van Gele, Mireille, De Schepper, Sofie, Lambert, Jo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053514/ https://www.ncbi.nlm.nih.gov/pubmed/27711196 http://dx.doi.org/10.1371/journal.pone.0164080

Ejemplares similares

Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
por: Lambert, Jo L. W., et al.
Publicado: (2021)

Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Characterization data on the topical carrier DDC642
por: Desmet, Eline, et al.
Publicado: (2016)

Learning From Success and Failure: Biologics for Non-approved Skin Diseases
por: Speeckaert, Reinhart, et al.
Publicado: (2019)

Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012)

Hypomelanoses in Children
por: van Geel, Nanja, et al.
Publicado: (2013)

Synthesis and characterization of non-viral liposomal carriers for the local application of siRNA molecules and anti-miRNAs in the therapeutic treatment of psoriasis
por: Bracke, Stefanie, et al.
Publicado: (2011)

From IL-17 to IFN-γ in inflammatory skin disorders: Is transdifferentiation a potential treatment target?
por: Belpaire, Arno, et al.
Publicado: (2022)

Emerging Topical and Systemic JAK Inhibitors in Dermatology
por: Solimani, Farzan, et al.
Publicado: (2019)

Autoimmunity in Segmental Vitiligo
por: Speeckaert, Reinhart, et al.
Publicado: (2020)

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response
por: De Wolf, Katrien, et al.
Publicado: (2017)

A single-stage bilayered skin reconstruction using Glyaderm® as an acellular dermal regeneration template results in improved scar quality: an intra-individual randomized controlled trial
por: De Decker, Ignace, et al.
Publicado: (2023)

Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
por: Chevolet, Ines, et al.
Publicado: (2015)

Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?
por: Delrue, Charlotte, et al.
Publicado: (2023)

Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2020)

Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy
por: De Langhe, Sofie, et al.
Publicado: (2014)

Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli
por: Lebeer, Sarah, et al.
Publicado: (2022)

Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases
por: Thielemans, Raïsa, et al.
Publicado: (2023)

The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach
por: Delrue, Charlotte, et al.
Publicado: (2022)

A meta-analysis of chemokines in vitiligo: Recruiting immune cells towards melanocytes
por: Speeckaert, Reinhart, et al.
Publicado: (2023)

Vitamin D Deficiency: An Underestimated Factor in Sepsis?
por: Delrue, Charlotte, et al.
Publicado: (2023)

The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023)

Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
por: Jin, Wenyu, et al.
Publicado: (2018)

Omega-3- and Resveratrol-Loaded Lipid Nanosystems for Potential Use as Topical Formulations in Autoimmune, Inflammatory, and Cancerous Skin Diseases
por: Caldas, Ana R., et al.
Publicado: (2021)

The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review
por: Speeckaert, Reinhart, et al.
Publicado: (2022)

The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis
por: Bao, Lei, et al.
Publicado: (2013)

Severe necrotising inflammatory skin reaction to topical 5-fluorouracil
por: Gokhale, Nikhil S
Publicado: (2019)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor
por: Chen, Ailynna, et al.
Publicado: (2023)

Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
por: Gómez-García, Francisco, et al.
Publicado: (2019)

CHILD syndrome: successful treatment of skin lesions with topical lovastatin and cholesterol lotion
por: Sandoval, Karina Romero, et al.
Publicado: (2019)

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Topical Microemulsions: Skin Irritation Potential and Anti-Inflammatory Effects of Herbal Substances
por: Leanpolchareanchai, Jiraporn, et al.
Publicado: (2023)

In Vivo Derm Dotting: An Easy and Inexpensive Way for Clinicopathological Correlation
por: Lanssens, Sven, et al.
Publicado: (2019)

Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa
por: Ablinger, Michael, et al.
Publicado: (2021)

JAK1 inhibition and inflammatory bowel disease
por: Harris, Clare, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9b6kg2r6dlgc1lendb7gvf2j2d